Millennium Management — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Cardurioncardurion.cominJul 2024 · $260M
Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBurlington, US
Michael E. Mendelsohn(Founder and Chief Strategy Officer)inMichael Mendelsohn, M.D.(Founder)in
Co-investorsBain CapitalDelos CapitalDigitalis VenturesNew Enterprise Associates (NEA)Ascenta CapitalBain Capital Life Sciences+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.